Clinical Trial Update: Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a Flushing Assessment Tool (FAST) in dyslipidemia patients treated with niacin extended-release plus aspirin; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Aspirin (Aspirin)
• Niaspan (niacin (nicotinic acid))

Snippet

Sponsor: Abbott | Conditions: Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2009-10-09